About
Neovasc Inc. is a specialty medical device company based in Richmond, British Columbia, Canada, founded in 2000. The company focuses on developing, manufacturing, and marketing innovative products for cardiovascular diseases. Its flagship product, the Neovasc Reducer System, is designed to treat refractory angina, a chronic condition that affects many patients who are not candidates for conventional therapies. The Reducer is a minimally invasive device that improves blood flow by narrowing a specific vein in the heart. It has received Breakthrough Device designation from the FDA and is CE-marked for use in Europe. In addition to the Reducer, Neovasc is developing the Neovasc Tiara, a transcatheter device for treating mitral valve disease and mitral regurgitation. This device offers a less invasive alternative to open-heart surgery. Neovasc also produces tissue products for cardiovascular applications, enhancing its portfolio in this specialized market. The company was acquired by Shockwave Medical in April 2023, further integrating its innovative technologies into a broader cardiovascular treatment platform.
Technologies
Keywords
Company Information
-
Employees 49
-
Founded 2008
-
Annual Revenue $3805000
-
Total Funding $107200000
Location
13700 Mayfield Pl, Richmond, British Columbia, Canada, V6V 2E4
